Novel Gene Therapy for Leukemia Clears FDA Panel – Scientific American
|
Novel Gene Therapy for Leukemia Clears FDA Panel
Scientific American A panel of outside experts convened by the FDA voted 10-0 Wednesday to recommend the approval of Novartis’ CAR-T therapy, called CTL019, for the treatment of children and young adults with advanced leukemia. The vote marks a pivotal milestone for this … |
PMLiVE |
Novartis’ CAR–T clears FDA panel with relative ease
PMLiVE In CAR-T therapy patients’ cells are harvested and modified so they are more likely to seek out and destroy cancer cells expressing a particular antigen, in this case CD19. Once reprogrammed the T cells are infused back into the patient in order to … |
|
Immunotherapy Drugs Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025
Medgadget (blog) Immunotherapy is the management of a disease by enhancing, suppressing, or inducing an immune response. Some immunotherapies are designed to magnify or elicit an immune response. They are known as activation immunotherapies. However, some … |